US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 25.500
  • +0.040+0.16%
Close Dec 20 16:00 ET
  • 25.500
  • 0.0000.00%
Post 20:05 ET
2.66BMarket Cap-11.54P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.334M--
--2024/Q4-- / 1.626M--
--2024/Q327.126M / 1.705M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.334M--
--2024/Q4-- / 1.626M--
--2024/Q327.126M / 1.705M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--

Unlock Free Earnings Estimates

NewAmsterdam Pharma Earnings Reports

  • 8-K: NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

    Nov 6 08:02 ET

  • 10-Q: Quarterly report

    Nov 6 08:02 ET

  • 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Oct 28 08:04 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 7 08:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data